The United States of America and T. RUDD CORWIN ("Defendant") hereby enter into the following Plea Agreement pursuant to Rule 11(c)(1)(C) of the Federal Rules of Criminal Procedure ("Fed. R. Crim. P."):
1. Defendant understands his rights:
AND WAIVE CERTAIN RIGHTS
2. Defendant waives the rights set out in Paragraph 1(b)-(g) above. Defendant agrees to have his sentence determined under the United States Sentencing Guidelines ("U.S.S.G.") and waives all constitutional challenges to the validity of the U.S.S.G. Defendant waives any right he may have to have facts that determine his Guidelines fine and imprisonment ranges under the U.S.S.G. (including any facts used to determine his offense level, volume of commerce, any specific offense characteristic or other enhancement or adjustment under the U.S.S.G.) alleged in an indictment and found by a jury beyond a reasonable doubt. Defendant also waives the right to appeal the imposition of the sentence against him, so long as the sentence imposed is consistent with the recommended sentence contained in Paragraph 8 of this Plea Agreement. Defendant also waives the right to file any collateral attack on his conviction or sentence, including a petition under 28 U.S.C. § 2255, at any time after he is sentenced, except for a claim that his constitutional right to the effective assistance of counsel was violated. Further, pursuant to Fed. R. Crim. P. 7(b), Defendant will waive indictment and plead guilty at arraignment to a one-count Information to be filed in the United States District Court for the Northern District of California. The Information will charge that beginning on or about July 1, 1999, and continuing until on or about June 15, 2002, Infineon Technologies AG ("Infineon AG"), including its United States-based subsidiary Infineon Technologies North America Corp. ("Infineon NA"), and co-conspirators participated in a conspiracy in the United States and elsewhere to suppress and eliminate competition by fixing the price of dynamic random access memory ("DRAM") to be sold to certain original equipment manufacturers of personal computers and servers ("OEMs"), in violation of the Sherman Antitrust Act, 15 U.S.C. § 1. The Information will further charge that Defendant, an employee of Infineon NA and its predecessor, joined and participated in the charged conspiracy during the period from on or about July 1, 1999, until on or about June 15, 2002.
3. Defendant, pursuant to the terms of this Plea Agreement, will plead guilty to the criminal charge described in Paragraph 2 above and will make a factual admission of guilt to the Court in accordance with Fed. R. Crim. P. 11, as set forth in Paragraph 4 below.
4. Had this case gone to trial, the United States would have presented evidence to prove the following facts:
(a) For purposes of this Plea Agreement, the "relevant period" is that period from on or about July 1, 1999, to on or about June 15, 2002. From July 1, 1999, to in or about October 1999, Defendant was a Director of Customer Marketing and Sales for the Memory Products Division of Siemens Microelectronics, Inc. From in or about October 1999 until October 2000, Defendant had the same job title, but the name of his corporate employer changed to Infineon NA. From in or about October 2000 to January 2002, the Defendant was Vice President for Customer Marketing and Sales for Memory Products in North America for Infineon NA. From in or about January 2002 to June 15, 2002, Defendant was Vice President of Sales, Computing Segment, for Infineon NA. Infineon NA is an entity organized and existing under the laws of Delaware and with its principal place of business in San Jose, California, and its predecessor Siemens Microelectronics, Inc., was an entity organized and existing under the laws of Delaware and with its principal place of business in San Jose, California. During the relevant period, Siemens Microelectronics, Inc., was a wholly-owned subsidiary of Siemens AG, an entity organized and existing under the laws of the Federal Republic of Germany ("Germany"), with its principal place of business in Munich, Germany; Infineon NA was a wholly-owned subsidiary of Infineon AG, an entity organized and existing under the laws of Germany, with its principal place of business in Munich, Germany.
(b) DRAM is the most commonly used semiconductor memory product. DRAM provides high-speed storage and retrieval of electronic information in personal computers, servers, and other devices. In the course of his employment for Infineon NA and its predecessor during the relevant period, Defendant was engaged in the sale of DRAM in the United States and also directly supervised other employees engaged in the sale of DRAM in the United States.
(c) During the relevant period, Defendant participated in a conspiracy in the manner described below, which conspiracy existed in the United States and elsewhere among certain DRAM producers and their officers and employees. The primary purpose of the conspiracy was to raise the price of DRAM sold to certain OEMs. The conspiracy directly affected these OEMs in the United States: Dell Inc., Hewlett-Packard Company, Compaq Computer Corporation, International Business Machines Corporation, Apple Computer Inc., and Gateway, Inc. In furtherance of the conspiracy, Defendant knowingly authorized, requested and consented to the participation of one or more subordinate employees in the conspiracy in the respects described below. The subordinate employees obtained from competitors the future pricing information of the competitors for DRAM to be sold to certain OEMs. Defendant understood that this competitor pricing information was sometimes obtained by the subordinates in exchange for Infineon pricing information for DRAM. Defendant also authorized, requested and consented to the subordinates providing this competitor pricing information to Defendant's superiors, as Defendant himself sometimes did. Defendant knew that the consequence of providing this information to Infineon's pricing decision-makers probably would be to stabilize or raise the price of DRAM sold to certain OEMs.
(d) During the relevant period, DRAM sold by one or more of the conspirators, equipment and supplies necessary to the production and distribution of DRAM, and payments for DRAM, traveled in interstate and foreign commerce. The business activities of Defendant and his co-conspirators in connection with the production and sale of DRAM affected by this conspiracy were within the flow of, and substantially affected, interstate and foreign trade and commerce.
(e) Acts in furtherance of this conspiracy were carried out within the Northern District of California. Furthermore, DRAM affected by this conspiracy was sold by one or more of the conspirators to customers in this District.
5. Defendant understands that the maximum penalty which may be imposed against him upon conviction for a violation of Section One of the Sherman Antitrust Act is:
(a) a term of imprisonment for three (3) years (15 U.S.C. § 1);
(b) a fine in an amount equal to the greatest of (1) $350,000, (2) twice the gross pecuniary gain the conspirators derived from the crime, or (3) twice the gross pecuniary loss caused to the victims of the crime by the conspirators (15 U.S.C. § 1; 18 U.S.C. § 3571(b) and (d)); and
(c) a term of supervised release of one (1) year following any term of imprisonment. If Defendant violates any condition of supervised release, Defendant could be imprisoned for the entire term of supervised release (18 U.S.C. § 3559(a)(5); 18 U.S.C. § 3583(b)(3) and (e)(3); and U.S.S.G. § 5D1.2(a)(3)).
6. In addition, Defendant understands that:
(a) pursuant to U.S.S.G. § 5E1.1, the Court may order him to pay restitution to the victims of the offense; and
(b) pursuant to 18 U.S.C. § 3013(a)(2)(A) and U.S.S.G. § 5E1.3, the Court is required to order Defendant to pay a $100.00 special assessment upon conviction for the charged crime.
7. Sentencing for the offense to be charged will be conducted pursuant to the U.S.S.G. Manual in effect on the day of sentencing. Pursuant to U.S.S.G. § 1B1.8, the United States agrees that self-incriminating information that Defendant provides to the United States pursuant to this Plea Agreement will not be used to increase the volume of affected commerce attributable to Defendant or in determining Defendant's applicable sentencing guidelines range, except to the extent provided in U.S.S.G. § 1B1.8(b). The United States and Defendant agree that the U.S. Sentencing Guidelines may be applied and, if applied, the applicable sentencing guidelines is U.S.S.G. § 2R1.1 with a base level of 10, a volume of commerce adjustment of plus 7 pursuant to U.S.S.G. § 2R1.1(b)(2)(G), for a total of 17; less a 3-level adjustment for timely acceptance of responsibility pursuant to U.S.S.G. § 3E1.1(a) and (b), for a total offense level of 14. Further, the United States agrees to make a motion for downward departure pursuant to Paragraph 10 below and U.S.S.G. § 5K1.1, recommending that Defendant be sentenced to the sentence agreed to below.
8. (a) Pursuant to Fed. R. Crim. P. 11(c)(1)(C), the United States and Defendant agree that the appropriate disposition of this case is, and agree to recommend jointly that the Court impose, a sentence requiring that Defendant pay to the United States a criminal fine of $250,000, pursuant to 15 U.S.C. § 1, payable in full before the thirtieth (30th) day after the date of judgment; a period of incarceration of 120 days; no order of restitution; and no period of supervised release ("the recommended sentence"). Defendant understands that this Court will order him to pay a $100 special assessment pursuant to 18 U.S.C. § 3013(a)(2)(A) and U.S.S.G. § 5E1.3 in addition to any fine imposed.
(b) The United States will not object to Defendant's request that the Court make a recommendation to the Bureau of Prisons that the Bureau of Prisons designate that Defendant be assigned to a Federal Minimum Security Camp (specifically to FPC Nellis, the Nellis Federal Prison Camp, near Las Vegas, Nevada) to serve his sentence of imprisonment and that Defendant be released on his own personal recognizance following the imposition of sentence to allow him to self-surrender to the designated institution on a specified date.
(c) The parties also agree that if the U.S. Sentencing Guidelines do not apply, this Court in exercising its unfettered discretion within the statutory limits for this offense should impose the same recommended sentence. Nothing in this Agreement shall preclude the United States from making a motion to reduce Defendant's sentence pursuant to Fed. R. Crim. P. 35(b) or otherwise, if circumstances so warrant.
9. The United States and Defendant agree that, pursuant to U.S.S.G. § 5E1.1(b), Defendant should not be ordered to pay restitution in light of the civil cases filed against Infineon NA, Defendant's employer, including In re DRAM Antitrust Litigation, No. M-02-1486-PJH, MDL No. 1486, in the United States District Court, Northern District of California, and DRAM Cases, No. CJC-03-004265, in the Superior Court, San Francisco, California, which potentially provide for a recovery of a multiple of actual damages.
10. The United States and Defendant agree that the applicable sentencing guidelines fine and incarceration ranges exceed the fine and term of imprisonment contained in the recommended sentence set out in Paragraph 8 above. Subject to the full and continuing cooperation of Defendant, as described in Paragraph 13 of this Plea Agreement, and prior to sentencing in this case, the United States agrees that it will make a motion, pursuant to U.S.S.G. § 5K1.1, for a downward departure from the guidelines sentence in this case. The motion for downward departure is based on cooperation that has already occurred and any additional cooperation that may occur prior to sentencing. Furthermore, the United States will request that this Court impose the fine and term of imprisonment contained in the recommended sentence set out in Paragraph 8 of this Plea Agreement because of Defendant's substantial assistance in the government's investigation and prosecutions of violations of federal criminal law in the DRAM industry.
11. The United States and Defendant jointly submit that this Plea Agreement, and the record that will be created by the United States and Defendant at the plea and sentencing hearing, will provide sufficient information concerning Defendant, the offense charged in this case, and Defendant's role in the offense to enable the meaningful exercise of sentencing authority by this Court under 18 U.S.C. § 3553. The United States will not object to Defendant's request that this Court accept Defendant's plea of guilty and impose sentence on an expedited schedule as early as the date of arraignment, based upon the record provided by Defendant and the United States, under the provisions of Rule 32(b)(1), Fed. R. Crim. P., U.S.S.G. § 6A1.1, and Criminal Local Rule 32-1(b). The Court's denial of the request to impose sentence on an expedited schedule will not void this Plea Agreement. Should the Court deny Defendant's request to impose sentence on an expedited schedule, the United States agrees that, at the initial appearance or arraignment, it will recommend the release of Defendant on his personal recognizance and without bond, under 18 U.S.C. § 3142, without restriction as to travel, pending the sentencing hearing in this case.
12. The United States and Defendant understand that this Court retains complete discretion to accept or reject the recommended sentence provided for in Paragraph 8 of this Plea Agreement.
(a) If this Court does not accept the recommended sentence, the United States and Defendant agree that this Plea Agreement, except for Paragraph 12(b) below, shall be rendered void. Neither party may withdraw from this Plea Agreement, however, based on the type or location of the correctional facility to which Defendant is assigned to serve his sentence.
(b) If this Court does not accept the recommended sentence, Defendant will be free to withdraw his guilty plea (Fed. R. Crim. P. 11(c)(5) and (d)). If Defendant withdraws his plea of guilty, this Plea Agreement, the guilty plea, and any statement made in the course of any proceedings under Fed. R. Crim. P. 11 regarding the guilty plea or this Plea Agreement or made in the course of plea discussions with an attorney for the government shall not be admissible against Defendant in any criminal or civil proceeding, except as otherwise provided in Fed. R. Evid. 410. In addition, should the Court not accept the Plea Agreement and should Defendant then withdraw his guilty plea, the United States agrees that it will dismiss the Information, without prejudice to the United States' right to indict Defendant on the charge contained in the Information and any other related charges. In addition, Defendant agrees that, if he withdraws his guilty plea pursuant to this subparagraph of the Plea Agreement, the statute of limitations period for any Relevant Offense, as defined in Paragraph 14 below, will be tolled for the period between the date of the signing of the Plea Agreement and the date Defendant withdrew his guilty plea or for a period of sixty (60) days after the date of the signing of the Plea Agreement, whichever is greater.
13. Defendant will cooperate fully and truthfully with the United States in the prosecution of this case, the conduct of the current federal investigation of violations of federal antitrust and related criminal laws involving the manufacture or sale of DRAM, any other federal investigation resulting therefrom, and any litigation or other proceedings arising or resulting from any such investigation to which the United States is a party ("Federal Proceeding"). The ongoing, full, and truthful cooperation of Defendant shall include, but not be limited to:
(a) producing in the United States and at other mutually agreed-upon locations all documents, including claimed personal documents, and other materials, wherever located, in the possession, custody, or control of Defendant, requested by attorneys and agents of the United States;
(b) making himself available for interviews in the United States and at other mutually agreed-upon locations, not at the expense of the United States, upon the request of attorneys and agents of the United States;
(c) responding fully and truthfully to all inquiries of the United States in connection with any Federal Proceeding, without falsely implicating any person or intentionally withholding any information, subject to the penalties of making false statements (18 U.S.C. § 1001) and obstruction of justice (18 U.S.C. § 1503);
(d) otherwise voluntarily providing the United States with any material or information, not requested in (a) - (c) of this paragraph, that he may have that is related to any Federal Proceeding; and
(e) when called upon to do so by the United States in connection with any Federal Proceeding, testifying in grand jury, trial, and other judicial proceedings in the United States, fully, truthfully, and under oath, subject to the penalties of perjury (18 U.S.C. § 1621), making false statements or declarations in grand jury or court proceedings (18 U.S.C. § 1623), contempt (18 U.S.C. §§ 401 - 402), and obstruction of justice (18 U.S.C. § 1503).
14. Subject to the full, truthful, and continuing cooperation of Defendant, as described in Paragraph 13 of this Plea Agreement, and upon the Court's acceptance of the guilty plea called for by this Plea Agreement and the imposition of the recommended sentence, the United States will not bring further criminal charges against Defendant for any act or offense committed before the date of this Plea Agreement that was undertaken in furtherance of an antitrust conspiracy involving the manufacture or sale of DRAM or undertaken in connection with any investigation of such a conspiracy ("Relevant Offense"). The nonprosecution terms of this paragraph do not apply to civil matters of any kind, to any violation of the federal tax or securities laws, or to any crime of violence.
15. Defendant understands that he may be subject to administrative action by federal or state agencies other than the United States Department of Justice, Antitrust Division, based upon the conviction resulting from this Plea Agreement, and that this Plea Agreement in no way controls whatever action, if any, other agencies may take. However, the United States agrees that, if requested, it will advise the appropriate officials of any governmental agency considering such administrative action of the fact, manner, and extent of the cooperation of Defendant as a matter for that agency to consider before determining what administrative action, if any, to take.
16. Defendant has reviewed all legal and factual aspects of this case with his attorney and is fully satisfied with his attorney's legal representation. Defendant has thoroughly reviewed this Plea Agreement with his attorney and has received satisfactory explanations from his attorney concerning each paragraph of this Plea Agreement and alternatives available to Defendant other than entering into this Plea Agreement. After conferring with his attorney and considering all available alternatives, Defendant has made a knowing and voluntary decision to enter into this Plea Agreement.
17. Defendant's decision to enter into this Plea Agreement and to tender a plea of guilty is freely and voluntarily made and is not the result of force, threats, assurances, promises, or representations other than the representations contained in this Plea Agreement. The United States has made no promises or representations to Defendant as to whether the Court will accept or reject the recommendations contained within this Plea Agreement.
18. Defendant agrees that, should the United States determine in good faith, during the period that any Federal Proceeding is pending, that Defendant has failed to provide full and truthful cooperation, as described in Paragraph 13 of this Plea Agreement, or has otherwise violated any provision of this Plea Agreement, the United States will notify Defendant or his counsel in writing by personal or overnight delivery or facsimile transmission and may also notify his counsel by telephone of its intention to void any of its obligations under this Plea Agreement (except its obligations under this paragraph), and Defendant shall be subject to prosecution for any federal crime of which the United States has knowledge including, but not limited to, the substantive offenses relating to the investigation resulting in this Plea Agreement. Defendant may seek Court review of any determination made by the United States under this Paragraph to void any of its obligations under the Plea Agreement. Defendant agrees that, in the event that the United States is released from its obligations under this Plea Agreement and brings criminal charges against Defendant for any Relevant Offense, the statute of limitations period for such offense will be tolled for the period between the date of the signing of this Plea Agreement and six (6) months after the date the United States gave notice of its intent to void its obligations under this Plea Agreement.
19. Defendant understands and agrees that in any further prosecution of him resulting from the release of the United States from its obligations under this Plea Agreement based on Defendant's violation of the Plea Agreement, any documents, statements, information, testimony, or evidence provided by him to attorneys or agents of the United States, federal grand juries, or courts, and any leads derived therefrom, may be used against him in any such further prosecution. In addition, Defendant unconditionally waives his right to challenge the use of such evidence in any such further prosecution, notwithstanding the protections of Fed. R. Evid. 410.
20. This Plea Agreement constitutes the entire agreement between the United States and Defendant concerning the disposition of the criminal charge in this case. This Plea Agreement cannot be modified except in writing, signed by the United States and Defendant.
21. The undersigned attorneys for the United States have been authorized by the Attorney General of the United States to enter this Plea Agreement on behalf of the United States.
22. A facsimile signature shall be deemed an original signature for the
purpose of executing this Plea Agreement. Multiple signature pages are authorized for the
purpose of executing this Plea Agreement.